?Sildenafil Citrate | GMP-Certified API for ED Treatment & Pulmonary Hypertension | USP Grade ????? | China | Manufacturer

Price	Get Latest Price
Package	1kg	25kg

Product Details

Product Name: Sildenafil citrate	CAS No.: 171599-83-0
Min. Order: 1kg	Purity: 99%
Supply Ability: 1T	Release date: 2025/02/26

Sildenafil Citrate | GMP-Certified API for ED Treatment & Pulmonary Hypertension | USP Grade 💊❤️‌

📌 ‌Product Overview‌

Sildenafil Citrate is a selective phosphodiesterase type 5 (PDE5) inhibitor primarily used to treat ‌erectile dysfunction (ED)‌ and ‌pulmonary arterial hypertension (PAH)‌‌12. By enhancing nitric oxide-mediated vasodilation, it improves blood flow to target tissues, offering rapid relief (onset: 30–60 minutes) and sustained efficacy (duration: 4–6 hours)‌23. Widely utilized in ‌pharmaceutical formulations‌ and ‌clinical research‌, it is compatible with oral tablets, compounded medications, and PAH-specific therapies‌24.

✅ ‌Key Advantages‌

🔥 ‌Feature‌	📈 ‌Specification/Effect‌
‌≥99% HPLC Purity‌	USP/EP-compliant with validated stability‌24
‌High Bioavailability‌	Rapid absorption (Cmax: 560 ng/mL at 1 hour)‌23
‌Broad Therapeutic Use‌	Dual applications in ED and PAH management‌25
‌Cost-Effective Synthesis‌	Scalable production under GMP guidelines‌24

🌍 ‌Applications‌

‌Pharmaceuticals‌
: Oral tablets (25mg/50mg/100mg) for ED and PAH‌23.
‌Research‌
: PDE5 inhibition studies and cardiovascular drug development‌25.
‌Compounding Pharmacies‌
: Customized dosage forms for niche patient needs‌24.
‌Veterinary Medicine‌
: Off-label use in animal cardiovascular research‌25.

📜 ‌Quality Certifications‌

‌GMP/ISO 9001‌
: Production aligns with WHO and ICH guidelines‌24.
‌USP/EP Compliance‌
: Rigorous testing via HPLC, GC-MS, and dissolution profiling‌24.
‌Residual Solvents‌
: <50 ppm (ICH Q3C standards)‌24.

📈 ‌Market Trends‌

The global ED drug market is projected to reach ‌$4.2B by 2027‌, driven by aging populations and lifestyle factors‌25. PAH therapies, including Sildenafil-based formulations, are growing at ‌6.8% CAGR‌, reflecting unmet clinical needs‌25.

Article illustration

Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

Recommended supplier

Product name	Price		Suppliers	Update time
Sildenafil citrate	$0.00/1G	VIP1Y	Forest chemical technology	2025-01-10
Sildenafil citrate	$1.00/1kg	VIP1Y	Shaanxi Xianhe Biotech Co., Ltd	2024-12-19
Sildenafil citrate	$31.00/25mg	VIP5Y	TargetMol Chemicals Inc.	2024-11-19
Sildenafil citrate	$31.00/25mg	VIP3Y	TargetMol Chemicals Inc.	2024-11-19
Sildenafil citrate	$20.00/1kg		Shaanxi Franta Biotechnology Co., Ltd	2024-09-25
Sildenafil Citrate	$1.00/1kg	VIP2Y	Jinan Million Pharmaceutical Co., Ltd	2024-07-10
Sildenafil Citrate	$0.00/25kg	VIP1Y	PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD	2024-05-15
Sildenaf citrate	$20.00/1g	VIP1Y	hebei hongtan Biotechnology Co., Ltd	2024-05-15
Sildenafil citrate	$0.00/1kg	VIP1Y	Hangzhou Hyper Chemicals Limited	2024-05-08
Sildenafil Citrate	$60.00/25kg		Ouhuang Engineering Materials (Hubei) Co., Ltd	2024-04-23

Sildenafil citrate NEW